Second Sight President & CEO Robert Greenberg, MD, PhD looks back on Second Sight’s long road to getting FDA approval for Argus II and considers the path not taken.
Robert Greenberg, MD, PhD
Dr. Greenberg currently serves as Chairman of the Board of Second Sight Medical Products. He is a Founder of the company and served as President, CEO and Director from 1998 until August 2015. From 1991 to 1997, Dr. Greenberg conducted pre-clinical and clinical trials demonstrating the feasibility of retinal electrical stimulation to elicit visual perceptions.